Multifidelity optimization can inform decision-making during process development and reduce the number of experiments ...

The supply chain is no longer a back-office afterthought. The global supply chain has become an essential business enabler and differentiator that can significa ...

Q3 2026 Earnings Call February 6, 2026 2:00 AM ESTCompany ParticipantsHiromichi Matsuda - President, CEO, Exe.

Good day, everyone, and welcome to Pfizer's Fourth Quarter 2025 Earnings Conference Call. Today's call is being recorded. At ...

Rational artificial intelligence sounds simple on paper: build systems that make sensible decisions based on goals, evidence, ...

Since its introduction in 1990, the commissioning layer of the NHS has been the most reorganised part of the health service, and it is changing once again. In this guest article, Nigel Edwards reviews ...

By Kwame Nyame, PhD.At an early stage in learning, we were told that economics is a science. However, the aspect that economics is a dismal science only dawned on us in the later stages of the ...

Dr. David Nathanson is a professor of molecular and medical pharmacology at UCLA. He received his Ph.D. in molecular and medical pharmacology at UCLA under Dr. Paul Mischel, where he discovered that ...

As data-driven ads lose impact, performance-creative strategies are helping brands blend data and creativity to produce more ...

Albert Bourla: 2025 was a very good year for Pfizer Inc. I'm very pleased with strong execution to deliver and, frankly, overdeliver on our financial commitments. If successful, we will substantially ...